Specifically, PLK1 has been shown to be upregulated in AML and preclinical studies targeting this enzyme have demonstrated induction of cell cycle arrest and apoptosis in cancer cells, especially leukemia cells [7–9]. The gene discussed is PLK1; the disease is acute myeloid leukemia.